Italy· 016762015
FULCIN 125*20 cpr 125 mg
A griseofulvin product containing griseofulvina, registered in Italy by SIT LABORATORIO FARMAC. Srl, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Griseofulvina
- Manufacturer
- SIT LABORATORIO FARMAC. Srl
- Country
- Italy (IT)
- ATC code
- D01AA08
- ATC class
- Griseofulvin
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic016762015FULCIN 125*20 cpr 125 mgEUR 2.17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
303 interactions on record for griseofulvin.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Griseofulvin · interactions on record
303 records
- 21 severe
- 262 moderate
- 20 minor
Most severe, free to view
- RanolazineC01EB18severe
- IUP aus Plastik mit GestagenG02BA03severe
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Griseofulvin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFulsovin 125mg/5ml oral suspensionKappin Ltd
- United StatesGriseofulvinSandoz Inc
- FinlandFulcinAstraZeneca UK Limited
- NorwayFulcinLaboratorio Farmaceutico S.I.T. Srl
- IrelandGriseofulvin 500 mg film-coated tabletsBrown & Burk IR Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Cyprus · Griseofulvin Remedica, Medofulvin
- France · Grisefuline
- United Kingdom (Northern Ireland) · Griseofulvin Brown & Burk Uk, Grisol
- Ireland · Griseofulvin Brown & Burk Ir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40883dea-41e5-46bf-a6c5-28823ffd24e5 GET /v1/drugs/40883dea-41e5-46bf-a6c5-28823ffd24e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 2.17,
"source": "aifa",
"currency": "EUR",
"strength": "GRISEOFULVINA 125MG 20 UNITA' USO ORALE",
"substance": "Griseofulvina",
"equivalence_group": "94A",
"transparency_flag": null
}See everything about griseofulvin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.